Subsets of solid tumors driven by translocation fusion events tend to be genetically simple, leading to deep and durable responses to targeted therapies.

“Even in solid tumors, you will find subsets of them that are driven by these translocation fusion events, and they tend to be genetically simple. And now time and time again, that has proven to be a population sparsely distributed, if you will, across cancer types where you get deep and durable responses.”